Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol. Issue 4 (14th December 2018)

• Record Type: Journal Article
• Authors: Samimi, Goli; Trabert, Britton; Geczik, Ashley M; Duggan, Máire A; Sherman, Mark E
• Is Part Of: JNCI cancer spectrum. Volume 2:Issue 4(2018)
• Publication Date: 2018-12-14
• DOI: 10.1093/jncics/pky061
• Languages: English
• ISSNs: 2515-5091

Abstract

Abstract: Frequent detection of serous tubal intraepithelial carcinoma (STIC) among BRCA1/ 2 mutation carriers undergoing risk-reducing surgery prompted the hypothesis that many adnexal high-grade serous carcinomas (HGSCs) arise from the fallopian tube, rather than the ovary, as supposed. The changing paradigm has important implications for HGSC prevention. Most data related to the frequency of STIC are derived from case series and estimates vary widely. Therefore, we analyzed population-based data from 10 523 surgeries including salpingectomy (Jan 2014–Dec 2016) that were examined using the "Sectioning and Extensively Examining the Fimbria" protocol, which optimizes STIC detection. Overall, STIC was detected in 40 (0.38%) specimens, including 32 diagnosed with concurrent gynecologic cancer. STIC was detected in 8 (<0.01%) of 9392 cases with benign diagnoses. We conclude that the relative rarity of STIC diagnoses in routine pathology practice has critical implications for research aiming to elucidate the pathogenesis of HGSC and developing prevention strategies.